New IVIG stored at room temperature
Privigen is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.
The first proline-stabilized intravenous immunoglobulin (IVIG) that can be stored at room temperature and does not require reconstitution has been approved by the FDA. Privigen (Immune Globulin Intravenous [Human] 10% Liquid), from CSL Behring, is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
